Scientists were surveyed as part of as assessment of five emerging biotechnologies which are potentially applicable to commercial U.S. maize production by the year 2000. The largest gains expected by scientists were from plant growth regulators, followed by photosynthetic enhancement, cell or tissue culture and biological nitrogen fixation.